Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Evaluation of sex hormone profile and semen parameters in acromegalic male patients.

Journal of endocrinological investigation·2026
Same author

Association between Epicardial Adipose Tissue Thickness and Clinical and Metabolic Parameters in Patients with Psoriasis and Psoriatic Arthritis: A Cross-Sectional Study from Türkiye.

Nigerian journal of clinical practice·2026
Same author

FROM 'NULL CELL ADENOMA' TO REFINED DIAGNOSIS: PITFALLS IN PITUITARY MASS EVALUATION.

Acta endocrinologica (Bucharest, Romania : 2005)·2026
Same author

Impulse control disorders in pituitary adenoma: What do we know and what we still don't know in almost two decades?

Pituitary·2025
Same author

Artificial Intelligence for Root Canal Orifice Identification Using Dental Operating Microscope Images: A Preliminary Evaluation.

Australian endodontic journal : the journal of the Australian Society of Endodontology Inc·2025
Same author

Artificial intelligence system for automatic tooth detection and numbering in the mixed dentition in CBCT.

European journal of paediatric dentistry·2025

Related Experiment Video

Updated: May 21, 2026

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

Xanthomatous hypophysitis.

M Niyazoglu1, O Celik, D V Bakkaloglu

  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Istanbul, Cerrahpasa Medical School, Endokrinoloji-Metabolizma ve Diyabet Bilim Dali, Cerrahpasa 34303, Istanbul, Turkey.

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|June 12, 2012
PubMed
Summary

Xanthomatous hypophysitis (XH), a rare pituitary condition, presents with specific symptoms and imaging findings. Early consideration of XH in pituitary lesion diagnosis is crucial for appropriate patient management.

More Related Videos

Induction of Experimental Autoimmune Hypophysitis in SJL Mice
10:38

Induction of Experimental Autoimmune Hypophysitis in SJL Mice

Published on: December 17, 2010

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Related Experiment Videos

Last Updated: May 21, 2026

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

Induction of Experimental Autoimmune Hypophysitis in SJL Mice
10:38

Induction of Experimental Autoimmune Hypophysitis in SJL Mice

Published on: December 17, 2010

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Area of Science:

  • Endocrinology
  • Pathology
  • Radiology

Background:

  • Xanthomatous hypophysitis (XH) is an uncommon primary inflammation of the pituitary gland.
  • Differential diagnosis for pituitary lesions includes Erdheim-Chester disease and Langerhans cell histiocytosis.

Observation:

  • A 39-year-old woman presented with headache, menstrual irregularities, and galactorrhea.
  • MRI revealed a 1cm pituitary lesion with a central cystic/necrotic area.
  • Histology showed foamy histiocytes and necrosis; immunohistochemistry was positive for CD68 and negative for CD1a and S100.

Findings:

  • The patient was diagnosed with Xanthomatous Hypophysitis based on clinical, imaging, and histological findings.
  • Glucocorticoid treatment was initiated for the diagnosed XH.

Implications:

  • Xanthomatous hypophysitis should be included in the differential diagnosis of pituitary lesions.
  • The rarity of XH complicates accurate assessment of treatment efficacy.